Enschede

Enschede's University of Twente drives a medtech and nanotech cluster with over 300 active startups, producing 60% more spinoffs per capita than the national benchmark. Compared to Utrecht, Enschede has 25% lower operational costs, and its medtech ventures achieve clinical trials 40% quicker than the industry norm. A standout: 1 in 3 spinoffs here holds an international patent.